1 Sanfrany N, Monnet DL. Antibiotics obtained without a prescription in Europe. Lancet Infect Dis. 2012;12:182.
http://dx.doi.org/10.1016/S473-3099(12)70017-8.
3 Zani EL, Clark OA, Rodrigues Netto N, Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011(5):CD006576.
doi: 10.1002/14651858.CD006576.pub2. PubMed PMID: 21563156.
4 Gasser M, Schrenzel J, Kronenberg A. Aktuelle Entwicklung der Antibiotikaresistenzen in der Schweiz. Swiss Med Forum. 2018;18(46):943–9.
5 Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, et al. Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches. Urology. 2017;104:11–21.
doi: 10.1016/j.urology.2016.12.011. PubMed PMID: 28007492.
6 Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, et al. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol. 2014;192(6):1673–8.
doi: 10.1016/j.juro.2014.06.005. PubMed PMID: 24928266.
7 Roberts MJ, Williamson DA, Hadway P, Doi SA, Gardiner RA, Paterson DL. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. Int J Antimicrob Agents. 2014;43(4):301–9.
doi: 10.1016/j.ijantimicag.2014.01.008. PubMed PMID: 24630305.
8 Walker JT, Singla N, Roehrborn CG. Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review. Rev Urol. 2016;18(2):73–89.
doi: 10.3909/riu0713. PubMed PMID: 27601966; PubMed Central PMCID: PMCPMC5010628.
9 Anderson E, Leahy O, Cheng AC, Grummet J. Risk factors for infection following prostate biopsy – a case control study. BMC Infect Dis. 2015;15:580.
doi: 10.1186/s12879-015-1328-7. PubMed PMID: 26700859; PubMed Central PMCID: PMCPMC4690315.
10 Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Roscigno M, et al. Is extended and saturation biopsy necessary? Int J Urol. 2010;17(5):432–47.
doi: 10.1111/j.1442-2042.2010.02479.x. PubMed PMID: 20415706.
11 Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521–7.
doi: 10.1016/j.eururo.2012.06.003. PubMed PMID: 22704727.
12 Shakil J, Piracha N, Prasad N, Kopacz J, Tarasuk A, Farrell R, et al. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization. Urology. 2014;83(4):710–3.
doi: 10.1016/j.urology.2013.12.039. PubMed PMID: 24680441.
13 Gyorfi JR, Otteni C, Brown K, Patel A, Lehman K, Phillips BE, et al. Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. World J Urol. 2014;32(4):905–9.
doi: 10.1007/s00345-014-1291-8. PubMed PMID: 24682238.
14 Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, et al. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int. 2014;114(3):384–8.
doi: 10.1111/bju.12536. PubMed PMID: 24612341.
15 Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–92.
doi: 10.1016/j.eururo.2013.05.049. PubMed PMID: 23787356.
16 Shahin O, Kwiatkowski M. Freehand MRI/US cognitive fusion transperineal biopsy of the prostata in local anesthesia. Annual meeting of the European Associaton of Urology, Barcelona 2019. 2019.
17 Zimmerman ME, Meyer AR, Carter HB, Allaf ME, Gorin MA. In-office Transperineal Prostate Biopsy Using Biplanar Ultrasound Guidance: a Step-by-Step Guide. Urology. 2019.
doi: 10.1016/j.urology.2019.07.021. PubMed PMID: 31374287.
18 Bennett HY, Roberts MJ, Doi SA, Gardiner RA. The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 2016;144(8):1784–91.
doi: 10.1017/S0950268815002885. PubMed PMID: 26645476.